Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 3 - Drugs for disorders of the metabolism
Patents for A61P 3 - Drugs for disorders of the metabolism (129,789)
08/2005
08/10/2005EP1560826A1 Pyridopyrimidinone compounds, method for production thereof and medicaments comprising the same
08/10/2005EP1560816A1 Quinazoline derivatives
08/10/2005EP1560598A1 Association between a heterocyclic compound stimulating lipid and carbohydrate metabolisms and an antioxidant agent for treating obesity
08/10/2005EP1560589A1 Novel complexes of fatty acid esters of polyhydroxyalkanes and pyridine carboxy derivatives
08/10/2005EP1560587A1 Cholesterol efflux and uses thereof
08/10/2005EP1560573A2 Therapeutic agents and corresponding treatments
08/10/2005EP1507514A4 Controlled release compositions of estradiol metabolites
08/10/2005EP1451166B1 Citric acid salt of a therapeutic compound and pharmaceutical compositions thereof
08/10/2005EP1399406B1 Novel estrogen receptor ligands and methods i
08/10/2005EP1392674B1 Furan and thiophene derivatives that activate human peroxisome proliferator activated receptors
08/10/2005EP1368340B1 Piperazine derivatives as melanocortin receptor agonists
08/10/2005EP1345946B1 Macroheterocylic compounds useful as kinase inhibitors
08/10/2005EP1339679B1 3-arylindole derivatives and their use as cb2 receptor agonists
08/10/2005EP1324760A4 Creatine ester pronutrient compounds and formulations
08/10/2005EP1292581B1 Bicyclic cyclohexylamines and their use as nmda receptor antagonists
08/10/2005EP1208103B1 Reverse-turn mimetics and methods relating thereto
08/10/2005EP1098891B1 Polycyclic thiazolidin-2-ylidene amines, method for the production and use thereof as medicaments
08/10/2005EP0833622B1 Compositions comprising a cyclooxygenase-2 inhibitor and a 5-lipoxygenase inhibitor
08/10/2005CN1653075A C-aryl glucoside SGLT2 inhibitors and method
08/10/2005CN1653073A Substituted phenylacetic acids
08/10/2005CN1653070A Heterocyclic amide derivatives as inhibitors of glycogen phoshorylase
08/10/2005CN1653068A Novel diazabicyclic biaryl derivatives
08/10/2005CN1653067A Carbazole derivatives and their use as NPY5 receptor antagonists
08/10/2005CN1653059A Macrocyclic compounds useful as pharmaceuticals
08/10/2005CN1653044A Pentafluorosulfanylbenzoylguanidines, processes for their preparation, their use as medicaments or diagnostic aids, and medicaments comprising them
08/10/2005CN1653042A Aminoalcohol derivatives as beta-3 adrenergic receptor agonists
08/10/2005CN1653040A HIF hydroxylase inhibitors
08/10/2005CN1653036A Amino acids with affinity for the alpha-2-delta-protein
08/10/2005CN1653025A NK1 antagonists
08/10/2005CN1652810A Immunosuppressant compounds, methods and uses related thereto
08/10/2005CN1652808A Hepatoprotective activity of 2'-p-hydroxybenzoylmussaenosidic
08/10/2005CN1652801A Mineral absorption promoter
08/10/2005CN1652788A Method of treating diabetes
08/10/2005CN1652786A Fluorinated 4-azasteroid derivatives as androgen receptor modulators
08/10/2005CN1652782A Nicotinamide derivatives useful as PDE4 inhibitors
08/10/2005CN1652779A Treatment of chemokine mediated diseases
08/10/2005CN1652778A Method for treating obesity
08/10/2005CN1652777A Combination of organic compounds
08/10/2005CN1652776A N3 alkylated benzimidazole derivatives as MEK inhibitors
08/10/2005CN1652774A Use of valsartan or its metabolite to inhibit platelet aggregation
08/10/2005CN1652770A Use of statins and other immunomodulatory agents in the treatment of autoimmune disease
08/10/2005CN1652761A Preventive or therapeutic agent for kidney disease
08/10/2005CN1652687A Choline-silicic acid complex with osmolytes and divalent trace elements
08/10/2005CN1651919A CD154 blockade monoclone antibody use for inhibiting rejection of insulin producing tissue transplantation
08/10/2005CN1651465A Glycosyl modified dietary fiber, its preparation method and application
08/10/2005CN1651433A Salviolic acid berberine double salt, its preparation method and application
08/10/2005CN1651431A Inhibitors of alpha L beta 2 mediated cell adhesion
08/10/2005CN1651087A Combination of organic compounds
08/10/2005CN1651085A Compound aspirin tading kind medicinal preparation and its application
08/10/2005CN1651059A Chinese medicine for treating diabetes
08/10/2005CN1651057A Cinnamon poria capsule and its preparation process
08/10/2005CN1651056A Cinnamon poria capsule and its preparation process
08/10/2005CN1651042A Compound aspirin red yeast extract medicinal preparation and its application
08/10/2005CN1651028A Medicinal composition having synergistic action
08/10/2005CN1651015A Chinese medicine for treating high cholesterol, high blood fat its preparation method
08/10/2005CN1651013A Medicine for treating diabetes
08/10/2005CN1651000A Liver clearing blood pressure lowering capsule nd its preparation method
08/10/2005CN1650994A Compound vitamin composition and its preparation
08/10/2005CN1650990A Chinese medicine for treating diabetes
08/10/2005CN1650970A Chinese medicinal preparation for treating heart brain blood vessel disease and its preparation method
08/10/2005CN1650964A Compound gingko leaf astruganus root medicinal preparation and its preparation method
08/10/2005CN1650951A Lycophyll mixture
08/10/2005CN1650939A Health care tea for preventing cancer, lowering blood fat and lowering blood pressure
08/10/2005CN1650921A Health care medicinal pillow
08/10/2005CN1650919A Prescription of Chinese medicine compound preparation, its preparation method and use
08/10/2005CN1650908A Method of extracting total flavone product from halenalin plant full flower
08/10/2005CN1650907A Zhogkang pill
08/10/2005CN1650905A Tangping hypoglycemic capsule
08/10/2005CN1650893A Health care product for treating intestine duct disease, preparation and use method thereof
08/10/2005CN1650891A Medicinal composition posssessing synergistic action
08/10/2005CN1650887A Compound sodium bialginat blood sugar reducing medicine
08/10/2005CN1650884A Effervescent agent using medium glycan or/and polysaccharide dief fiber as functional component
08/10/2005CN1650873A Fructose for injection and its preparation method
08/10/2005CN1650870A Berberine compound sugar reducing medicine
08/10/2005CN1650858A Blood fat reducing composition containing avatatin and its use
08/10/2005CN1650857A Coating method of vitamin C
08/10/2005CN1650852A L-lysine bydrochloride aseptic powder agent for injection and its preparation method
08/10/2005CN1214043C Humanized antibodies to gamma-interferon
08/10/2005CN1214022C Vitamin D analogues
08/10/2005CN1214017C 四唑衍生物 Tetrazole derivatives
08/10/2005CN1214011C Meta-azacyclic amino benzoic acid compound and derivatives thereof being integrin antagonists
08/10/2005CN1214008C Therapeutic biaryl derivatives
08/10/2005CN1214006C Novel vitamin D derivatives with cyclopropyl rings in lateral chains, its production method and intermediate and utilization thereof for producing medicaments
08/10/2005CN1213980C Vitamin D analogues
08/10/2005CN1213763C Oral liquor for treating diabetes and preparation method thereof
08/10/2005CN1213758C Application of Galium L. in medicine for curing diabetes
08/10/2005CN1213744C Remedies
08/10/2005CN1213738C High mechanical stability solid oral dosage form with slow releasing function for active composition
08/09/2005US6927317 Modulating ramp activity
08/09/2005US6927288 Plant thermogenic genes and proteins
08/09/2005US6927234 possessing anti-cancer activity, anti-inflammatory activity, anti-obesity activity, and/or hair growth promotion activity
08/09/2005US6927228 Biphenyl compounds usefuf in treatment of human and veterinary medicines such as dermatology, cardivovascular diseases, immune diseases or diseases associated with lipid metabolisms, or in cosmetic formulation
08/09/2005US6927227 Heterocyclic containing biphenyl aP2 inhibitors and method
08/09/2005US6927224 Anticancer agents; osteoporosis
08/09/2005US6927222 Compounds
08/09/2005US6927219 Secondary amides such as N-Adamantan-1-methyl-2-chloro-5-(3,5-dioxo-4,5-dihydro-3H- (1,2,4)triazin-2-yl)-benzamide used as antagonists for biological receptors; antiinflammatiory, anticarcinogenic or antiischemic agents
08/09/2005US6927218 Aryl N-cyanoguanidines and methods related thereto
08/09/2005US6926912 Metal compounds, mixed or sulphated, as phosphate binders
08/09/2005US6926898 Albumin fusion proteins
08/09/2005CA2327029C Method for making 4-carboxyamino-2-substituted-1,2,3,4-tetrahydroquinoline
1 ... 707 708 709 710 711 712 713 714 715 716 717 718 719 720 721 722 723 724 725 726 727 ... 1298